In my opinion the ethical decision is if the drug is approved, then we should do the clinical trials in Albania and use part of the profits to start a compassionate use program in Albania, even if creating a distribution system and training doctors to administer the drug, monitor patients for adverse effects, and monitor outcomes will involve considerable expense. Since clinical trials have started in Albania, an entrepreneur should want to continue supplying them with the drug. While it might be expensive to implement doctors and distribution systems in Albania, it would have been the same, if not more expensive, to implement the same system in the United States. Since Albania is not that rich, patients who started the clinical trial would be adequately dependent on the drug. Dr. Hassan should look ahead and plan for the prices of manufactured goods in both the United States and Albania because this could create jobs in that area. If produced in the United States and profits were higher it could cover some of the expenses in Albania. Say no to plagiarism. Get a tailor-made essay on "Why Violent Video Games Shouldn't Be Banned"? Get an original essay Ethical dilemma cases are problems or problematic situations that require a person or company to choose between alternatives that must be evaluated as right (ethical) or wrong In my opinion the third scenario is the most feasible because it is least expensive and takes less time. The objective of this report was to inform Dr Ibrahim Hassan about the successes and challenges experienced in conducting a training program on research ethics in clinical trials in Albania, we report several key issues that emerged during this research and which may serve as a strong reference to guide the planning and implementation of similar training programs in the future. This program will help the poor population of Albania. Therefore, I cannot offer the dramatic relief and then snatch it away. A critical component of clinical trials is the need to understand the historical and philosophical basis for the application of bioethical principles by understanding research codes and ethical guidelines. The third scenario seems the most feasible both in terms of ethical conduct and from a business point of view, since in Albania there is abundant workforce available both in the medical and medical fields. Furthermore, the project timeline would also increase. Since Dr. Hassan's roots come from an underdeveloped country, he is more sensitive to the well-being of underprivileged citizens, so this decision would help the Albanian people in the following ways in addition to benefiting the US market. It would help increase the income of doctors and selected individuals, as well as increase the overall GDP of the country. It would give further credit to the Albanian people as they have pioneered the clinical research of this new drug. It would give cutting-edge care to the poor people of Albania through an operational scheme. It will help conduct the subjects' track record for any subsequent adverse effects. It would increase diplomatic relations between the United States and Albania. It would open new trade routes between two countries. Considering the third option, it is obvious that spending money is a must, either for doctors and subjects in the United States (which will not only be expensive and time consuming, but also critical) or to create a compassionate use program which will once again be very useful for keeping track of medications and its long-term effects allow you to obtain the drug certificate and the entire procedure in a much shorter time and to provide the good to people in need without any.